Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chii-Min Hwu"'
Autor:
Fu Shun Yen, Chih Cheng Hsu, James Cheng-Chung Wei, Chii Min Hwu, Chia Ling Chang, Chen Chang Yang
Publikováno v:
International Journal of Medical Sciences
Objectives: Chronic kidney disease (CKD) has emerged as a global health concern. Many studies have identified an association between hyperuricemia and CKD, and some studies have revealed that urate-lowering therapy (ULT) can attenuate CKD progression
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0234909 (2020)
PLoS ONE, Vol 15, Iss 6, p e0234909 (2020)
ObjectivesAlthough studies have demonstrated the association of hyperuricemia with cardiovascular (CV) diseases, few have explored the effect of urate-lowering therapy (ULT) on the incidence of CV diseases. Therefore, we compared the risks of hospita
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
Substantial evidence has demonstrated a close relationship between hyperuricemia and cardiovascular (CV) diseases, but few studies have explored the possibility of using urate-lowering therapy (ULT) to attenuate the development of CV diseases. To com
Autor:
Josyf C. Mychaleckyj, Timothy D. O’Connor, Eric Boerwinkle, Yii-Der Ida Chen, Chii-Min Hwu, John Blangero, D. C. Rao, Patricia A. Peyser, Susan Redline, Shamil R. Sunyaev, Christian Gilissen, Esteban G. Burchard, Jerome I. Rotter, Ryan D. Hernandez, Braxton D. Mitchell, Courtney G. Montgomery, Stephen T. McGarvey, Sharon L.R. Kardia, Jakob M. Goldmann, Kathleen C. Barnes, Lisa de las Fuentes, Lawrence F. Bielak, Jiang He, Patrick T. Ellinor, Jennifer A. Smith, Peter V. Kharchenko, Ani Manichaikul, Wendy S.W. Wong, Adolfo Correa, Vladimir B. Seplyarskiy, Donna K. Arnett, Scott T. Weiss, Ruslan A. Soldatov, Edwin K. Silverman, Nicholette D. Palmer, Ryan J. McGinty, Stephen S. Rich, Leslie S. Emery, Vasan S. Ramachandran, Jennifer A. Brody
Mechanistic processes underlying human germline mutations remain largely unknown. Variation in mutation rate and spectra along the genome is informative about the biological mechanisms. We statistically decompose this variation into separate processe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4889223e95f444d6209b4b07f75123f
https://doi.org/10.1101/2020.01.10.893024
https://doi.org/10.1101/2020.01.10.893024
Autor:
Jung-Nien Lai, Fu-Shun Yen, Chii-Min Hwu, James Cheng-Chung Wei, Ming-Chih Hou, Chih-Cheng Hsu, Lu-Ting Chiu
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243783 (2020)
PLoS ONE
PLoS ONE
This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonu
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss, Pp S90-S95 (2019)
Background/Purpose: We investigated hospitalization rates of patients with type 2 diabetes mellitus (T2DM) and individuals without diabetes mellitus (non-DM) in a disease-specific manner from 2005 to 2014 in Taiwan. Methods: This population-based stu
Publikováno v:
Medicine. 100:e25085
Type 2 diabetes mellitus (T2DM) is a progressive disease. After metformin failure, the addition of insulin or sulfonylureas might increase the risk of hypoglycemia and cardiovascular (CV) morbidity. Here, the risk of all-cause mortality was compared
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 25(11)
Objective: Upstroke time per cardiac cycle (UTCC) in the lower extremities has been found to be predictive of cardiovascular mortality in the general population. Therefore, the purpose of the study was to test the associations between increasing UTCC
Autor:
James Cheng-Chung Wei, Chii-Min Hwu, Chun-Wei Pan, Hsiang-Chi Wang, Fu-Shun Yen, Chih-Cheng Hsu
Publikováno v:
The Journal of clinical endocrinology and metabolism. 105(3)
Context The long-term safety and benefit of pioglitazone use in combination with insulin are still uncertain. Objective This study compared the risks of all-cause mortality and major cardiovascular (CV) events between pioglitazone users and nonusers
Autor:
Chii-Min Hwu, Yu Hsin Yen, Chih-Cheng Hsu, Fu-Shun Yen, Boniface J. Lin, Jen-Huai Chiang, James Cheng-Chung Wei
Publikováno v:
BMC Endocrine Disorders
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-7 (2019)
Background Dipeptidyl peptidase-4 (DPP-4) inhibitors could effectively reduce HbA1C and postprandial hyperglycemia and could incur only minimal danger of hypoglycemia. Patients with uncontrolled diabetes might be treated by the complementary action o